Having trouble accessing articles? Reset your cache.

Rozrolimupab: Phase II data

A dose-escalation, open-label Phase II trial in 38 evaluable Rhesus D (RhD)-positive, non-splenectomized patients

Read the full 144 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE